Assyro AI

FDA Orange Book · active-ingredient family

Nitazoxanide

Nitazoxanide is approved as 2 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:ALINIA · NDA 021497

2

Brand (NDA)

3

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · for suspension, tablet

ProductApplicantApplicationTEApproved
ALINIARLDROMARKNDA 021497Jul 21, 2004
ALINIARLDROMARKNDA 021498Nov 22, 2002

Generic (ANDA) products (3)

ProductApplicantApplicationTEApproved
NITAZOXANIDEANNORA PHARMAANDA 218701ABApr 15, 2025
NITAZOXANIDEANI PHARMSANDA 214844ABFeb 03, 2025
NITAZOXANIDERISINGANDA 213820ABNov 27, 2020

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Nitazoxanide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.